Literature DB >> 19821783

The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families.

Anna Radominska-Pandya1, Stacie M Bratton, Matthew R Redinbo, Michael J Miley.   

Abstract

Human UDP-glucuronosyltransferases (EC 2.4.1.17) (UGTs) are major phase II metabolism enzymes that detoxify a multitude of endo- and xenobiotics through the covalent addition of a glucuronic acid moiety. UGTs are promiscuous enzymes that regulate the levels of numerous important endobiotics in a range of tissues, and inactivate most therapeutic compounds in concert with phase I enzymes. In spite of the importance of these enzymes, we have only a limited understanding of the molecular mechanisms governing their substrate specificity and catalytic activity. Until recently, no three-dimensional structural information was available for any mammalian UGT. The 1.8-å resolution apo crystal structure of the UDP-glucuronic acid binding domain of human UGT2B7 (2B7CT) is the only structure of a mammalian UGT target determined to date. In this review, we summarize what has been learned about human UGT function from the analysis of this and other related glycosyltransferase (GT) crystal structures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19821783      PMCID: PMC3192453          DOI: 10.3109/03602530903209049

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  48 in total

Review 1.  Glycosyltransferase structure and mechanism.

Authors:  U M Unligil; J M Rini
Journal:  Curr Opin Struct Biol       Date:  2000-10       Impact factor: 6.809

2.  The 1.9 A crystal structure of Escherichia coli MurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis.

Authors:  S Ha; D Walker; Y Shi; S Walker
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

3.  An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyltransferase 1A6 to the endoplasmic reticulum.

Authors:  M Ouzzine; J Magdalou; B Burchell; S Fournel-Gigleux
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

4.  Identification of aspartic acid and histidine residues mediating the reaction mechanism and the substrate specificity of the human UDP-glucuronosyltransferases 1A.

Authors:  Dong Li; Sylvie Fournel-Gigleux; Lydia Barré; Guillermo Mulliert; Patrick Netter; Jacques Magdalou; Mohamed Ouzzine
Journal:  J Biol Chem       Date:  2007-10-23       Impact factor: 5.157

5.  Comparative modelling of the human UDP-glucuronosyltransferases: insights into structure and mechanism.

Authors:  C W Locuson; T S Tracy
Journal:  Xenobiotica       Date:  2007-02       Impact factor: 1.908

6.  Crystal structure of Medicago truncatula UGT85H2--insights into the structural basis of a multifunctional (iso)flavonoid glycosyltransferase.

Authors:  Lenong Li; Luzia V Modolo; Luis L Escamilla-Trevino; Lahoucine Achnine; Richard A Dixon; Xiaoqiang Wang
Journal:  J Mol Biol       Date:  2007-05-18       Impact factor: 5.469

7.  Phenylalanine 90 and 93 are localized within the phenol binding site of human UDP-glucuronosyltransferase 1A10 as determined by photoaffinity labeling, mass spectrometry, and site-directed mutagenesis.

Authors:  Yan Xiong; Dan Bernardi; Stacie Bratton; Michael D Ward; Eric Battaglia; Moshe Finel; Richard R Drake; Anna Radominska-Pandya
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

8.  Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.

Authors:  Michael J Miley; Agnieszka K Zielinska; Jeffrey E Keenan; Stacie M Bratton; Anna Radominska-Pandya; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

9.  Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4.

Authors:  Takahiro Kubota; Benjamin C Lewis; David J Elliot; Peter I Mackenzie; John O Miners
Journal:  Mol Pharmacol       Date:  2007-07-17       Impact factor: 4.436

10.  Structure of a flavonoid glucosyltransferase reveals the basis for plant natural product modification.

Authors:  Wendy Offen; Carlos Martinez-Fleites; Min Yang; Eng Kiat-Lim; Benjamin G Davis; Chris A Tarling; Christopher M Ford; Dianna J Bowles; Gideon J Davies
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

View more
  15 in total

1.  Accurate prediction of glucuronidation of structurally diverse phenolics by human UGT1A9 using combined experimental and in silico approaches.

Authors:  Baojian Wu; Xiaoqiang Wang; Shuxing Zhang; Ming Hu
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

2.  Pyrethroid activity-based probes for profiling cytochrome P450 activities associated with insecticide interactions.

Authors:  Hanafy M Ismail; Paul M O'Neill; David W Hong; Robert D Finn; Colin J Henderson; Aaron T Wright; Benjamin F Cravatt; Janet Hemingway; Mark J I Paine
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

3.  Two Novel Fungal Phenolic UDP Glycosyltransferases from Absidia coerulea and Rhizopus japonicus.

Authors:  Kebo Xie; Xiaoxiang Dou; Ridao Chen; Dawei Chen; Cheng Fang; Zhiyan Xiao; Jungui Dai
Journal:  Appl Environ Microbiol       Date:  2017-03-31       Impact factor: 4.792

Review 4.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

Review 5.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

Review 6.  Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.

Authors:  Dong Dong; Roland Ako; Ming Hu; Baojian Wu
Journal:  Xenobiotica       Date:  2012-03-02       Impact factor: 1.908

7.  Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes.

Authors:  Robyn Meech; Anne Rogers; Lizhe Zhuang; Benjamin C Lewis; John O Miners; Peter I Mackenzie
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

8.  Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing.

Authors:  Adrien Labriet; Eric P Allain; Michèle Rouleau; Yannick Audet-Delage; Lyne Villeneuve; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2018-02-09       Impact factor: 3.922

9.  Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes.

Authors:  Michael J Osborne; Luciana Coutinho de Oliveira; Laurent Volpon; Hiba Ahmad Zahreddine; Katherine L B Borden
Journal:  J Mol Biol       Date:  2018-11-11       Impact factor: 5.469

10.  UGT84F9 is the major flavonoid UDP-glucuronosyltransferase in Medicago truncatula.

Authors:  Olubu A Adiji; Maite L Docampo-Palacios; Anislay Alvarez-Hernandez; Giulio M Pasinetti; Xiaoqiang Wang; Richard A Dixon
Journal:  Plant Physiol       Date:  2021-04-23       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.